Codeine Addiction: Signs, Risks, Lean/Purple Drank, Withdrawal, and Treatment

Codeine is a natural opioid derived from the opium poppy and one of the most widely used opioid medications in the world. Prescribed for mild to moderate pain and as a cough suppressant, it is often perceived as less dangerous than other opioids, a perception that contributes to underestimating its addictive potential. A 2016 study found that codeine carries the same risks for developing dependence and addiction as any other prescription opioid.

According to StatPearls (NCBI), codeine is the most commonly taken opioid medication judging by the number of countries where it is used worldwide. Codeine dependence accounts for approximately 2% of admissions to substance abuse treatment centers in the United States. In 2021, 26.4% of prescription pain reliever misusers, about 2.3 million people, specifically misused codeine products, making it the third most commonly misused prescription painkiller.

What Is Codeine?

Codeine (3-methylmorphine) is a natural opioid that occurs naturally in opium from the poppy plant and acts as an agonist at opioid receptors in the brain and nervous system. After ingestion, much of its effect comes from the body metabolizing codeine into morphine, which then binds to mu-opioid receptors (primary type of opioid receptor in the brain) to produce pain relief, sedation, and euphoria.

Codeine is available in several forms:

• Codeine/acetaminophen tablets: The most common prescription form for pain. High-dose misuse carries acetaminophen liver toxicity risk.
• Codeine/promethazine syrup: Prescribed for cough. Promethazine is a sedating antihistamine that amplifies codeine’s central nervous system depression; the combination is significantly more dangerous than codeine alone.
• Codeine/guaifenesin cough syrup: Available OTC in some states; guaifenesin is an expectorant with no psychoactive effect.
• Pure codeine (Schedule II): Less commonly prescribed; combination products containing codeine fall under Schedule III–V depending on formulation.

Lean / Purple Drank: A Cultural and Clinical Concern

“Lean,” also known as purple drank, sizzurp, syrup, and dirty sprite, is a recreational drug preparation made by mixing codeine-promethazine cough syrup with soda (typically Sprite or Mountain Dew) and often candy. It originated in Houston’s hip-hop scene in the 1990s and has been widely referenced in popular music, which has contributed to its normalization, particularly among young people.

Lean is far more dangerous than its casual cultural image suggests. The combination of codeine (an opioid) with promethazine (a potent sedating antihistamine) significantly amplifies CNS (Central Nervous System) and respiratory depression beyond what codeine alone would cause. Because the preparation is consumed as a sweet drink in variable, unmeasured quantities, overdose risk is high, especially when mixed with alcohol or benzodiazepines. Counterfeit syrups may also contain fentanyl, dramatically increasing lethality.

Research on lean use has found that among people who use it regularly, 74% have experienced withdrawal symptoms, 63% have experienced overdoses, and 91% meet criteria for a substance use disorder. DJ Screw, the Houston rapper credited with popularizing lean in music, died of a codeine-promethazine overdose in 2000.

How Codeine Addiction Develops

Codeine addiction can develop from both prescription use and recreational misuse. Because codeine is often perceived as a mild opioid, patients may not recognize the warning signs of developing dependence, and prescribers may not counsel them as thoroughly about addiction risk as they would with stronger opioids. This perception gap creates a particular hazard.

Tolerance to codeine’s pain-relieving and euphoric effects develops with regular use, prompting dose escalation. Physical dependence follows, meaning the body requires codeine to function normally and generates withdrawal symptoms when it is reduced or stopped. For recreational users, the sweet taste and social context of lean consumption can mask the progressive development of dependence.

An important metabolic consideration: approximately 7–10% of the population are “ultra-rapid metabolizers” of codeine. Their bodies convert it to morphine unusually quickly, producing dangerously high morphine levels even from standard doses. At the other extreme, poor metabolizers (about 7–10%) receive little to no pain relief from codeine, which can prompt dose escalation. These genetic differences make codeine’s safety and efficacy profile more variable than other opioids.

Signs of Codeine Addiction

Codeine addiction shows up in behavior, the body, and mental health:

Codeine Overdose: Risks and Recognition

Codeine overdose, like any opioid overdose, is a life-threatening emergency. The most immediately dangerous effect is severe respiratory depression: slowed or stopped breathing that deprives the brain of oxygen, potentially causing brain damage, coma, and death. Risk is substantially increased when codeine is combined with alcohol, benzodiazepines, promethazine (as in lean), or other CNS depressants.

Signs of codeine overdose requiring immediate emergency response:

• Slow, shallow, or stopped breathing
• Unresponsive or unable to be woken
• Blue or grayish lips, fingernails, or skin (cyanosis)
• Pinpoint pupils
• Cold, clammy skin
• Severe drowsiness, stupor, or coma

If overdose is suspected: call 911 immediately, administer naloxone (Narcan) if available, place the person on their side to prevent choking, and stay with them until emergency services arrive. Naloxone reverses opioid overdose and is available without a prescription at most pharmacies.

Codeine Withdrawal

Codeine withdrawal is similar in character to withdrawal from other opioids but is typically less severe due to codeine’s lower potency. It is nonetheless intensely uncomfortable and a major driver of relapse. Quitting abruptly without medical support is not recommended because tolerance loss during abstinence means that relapse at a previously tolerated dose can cause fatal overdose.

Codeine withdrawal typically includes:

• Onset: Symptoms begin within 6 to 24 hours of the last dose
• Peak: Most intense between 36 and 72 hours
• Duration: Physical symptoms resolve within 5 to 10 days; psychological symptoms including cravings and mood disturbances can persist weeks to months

Common withdrawal symptoms include:

• Muscle aches, restlessness, and restless legs
• Sweating, chills, and goosebumps
• Nausea, vomiting, and diarrhea
• Anxiety, agitation, and insomnia
• Yawning, teary eyes, and runny nose

Treatment for Codeine Addiction

Codeine addiction is treated with the same evidence-based approaches used for all opioid use disorders. The same FDA-approved medications that effectively treat heroin or oxycodone addiction also work for codeine. The specific opioid matters less than addressing the underlying opioid use disorder.

• Buprenorphine (Suboxone): Partial opioid agonist that prevents withdrawal and suppresses cravings. Prescribable by any DEA-registered provider since the 2023 X-waiver elimination (a special federal certification that U.S. doctors previously needed to prescribe buprenorphine for addiction treatment; eliminated in 2023, allowing any DEA-registered provider to prescribe it).
• Methadone: Full opioid agonist that eliminates withdrawal and cravings. Dispensed daily through federally certified Opioid Treatment Programs.
• Naltrexone (Vivitrol): Opioid blocker. Requires 7 to 14 days opioid-free before initiation.
• Behavioral therapies: CBT, motivational interviewing, and peer support address the psychological dimensions and support long-term recovery.

Professional Perspective

“Codeine is often marketed in the form of tablets and syrups. While opioids are valuable agents for treating pain, they also carry a high risk of misuse, abuse, addiction, and increased mortality, as demonstrated by the current opioid epidemic and accompanying overdose deaths.”

National Center for Biotechnology Information

Source: Codeine, NCBI

This statement is particularly important for codeine because it is so often assumed to be safer than it is. The fact that codeine is available over the counter in some countries, is prescribed for minor coughs, and is consumed in popular cultural contexts as a sweet drink has created a false impression that it poses minimal addiction risk. The clinical evidence does not support that impression. Codeine is an opioid, subject to all the same addiction dynamics as other opioids in its class.

What This Means When Looking for Treatment

Codeine addiction may feel less serious than addiction to heroin or fentanyl, but it is a legitimate medical condition that benefits from professional treatment. If you or someone you love is unable to stop codeine use, is experiencing withdrawal between doses, or is using lean regularly, help is available and effective.

Speaking with a healthcare provider or addiction specialist is the right first step. Medication-assisted treatment works for codeine use disorder just as it does for all opioid use disorders, and the earlier treatment begins, the better the outcomes.